Is tumor necrosis factor genotype (TNFA2/TNFA2) a genetic prognostic factor of an unfavorable outcome in IgA nephropathy?

Journal of Korean Medical Science

Volumn 16, Issue 6, 2001, Pages 751-755

  Lee, Eun Young ^a   Yang, Dong Ho ^a   Hwang, Kyu Yoon ^a   Hong, Sae Yong ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Glomerulonephritis, IgA; Polymorphism (Genetics); Tumor Necrosis Factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BIOPSY; DISEASE COURSE; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PATHOLOGY; PREDICTION AND FORECASTING; PREVALENCE; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BIOPSY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLOMERULONEPHRITIS, IGA; HUMAN; LYMPHOTOXIN; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0035653812     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.6.751     Document Type: Article

References (18)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-27.
2. Waldherr R, Noronha IL, Niemir Z, Kruger C, Stein H, Stumm G. Expression of cytokines and growth factors in human glomerulonephritides. Pediatr Nephrol 1993; 7: 471-8.
3. Matsumoto K. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis. Clin Nephrol 1993; 40: 148-54.
4. Carroll MC, Katzman P, Alicot EM, Koller BH, Geraghty DE, Orr HT, Strominger JL, Spies T. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987; 84: 8535-9.
5. Abboud HE. Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-67.
6. Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988; 141: 3050-4.
7. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381-4.
8. Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, Riethmuller G, Weiss EH. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209-19.
9. Pujol-Borrell R, Todd I, Doshi M, Bottazzo GF, Sutton R, Gray D, Adolf GR, Feldmann M. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature 1987; 326: 304-6.
10. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat I, Moore RH. Autoimmune renal disease and tumour necrosis factor beta gene polymorphism. Clin Nephrol 1993; 40: 63-8.
11. Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1: 353.
12. Lee SM, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, Katz AI. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-22.
13. Baud L, Fouqueray B, Philippe C, Amrani A. Tumor necrosis factor alpha and mesangial cells. Kidney Int 1992; 41: 600-3.
14. Diamond JR, Pesek I. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Lab Invest 1991; 64: 21-8.
15. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
16. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, Grennan D. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1995; 12: 127-33.
17. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-9.
18. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-37.